Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma
10.4085/1062-6050-356-19 79 TangC.WangZ.XieY.FeiY.LuoJ.WangC.et al (2024)
In the COMBINE 1 study, the Kyinsu group achieved an HbA1c reduction of 1.55 percent from baseline, compared with a 0.89 percent reduction in the insulin icodec group
Interim analysis of a phase ii study of the glutaminase inhibitor telaglenastat (Cb-839) in combination with azacitidine in advanced myelodysplastic syndrome (Mds)
US$ 22.24
US$ 27.89
US$ 21.59
US$ 23.14
US$ 29.01
US$ 22.36
US$ 27.11
US$ 29.71
